Fact check · Version 1 · Sources checked
“P21 improves memory or treats Alzheimer’s disease in people.”
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Not established
The reviewed evidence does not establish this statement. This does not prove it can never be true.
The reviewed studies used mice, rats, or cells. The P021 registry search found no study in people. Animal or cell findings cannot show that P21 treats people.
- What this answer is based on
- No reliable study in people shows the health outcome in this statement.
- Limits of this answer
- Memory or Alzheimer’s disease outcomes in people who received a verified P21 study product. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- What a study measured about people's health, symptoms, or ability to function.
Sources for this fact check
Show 5 sources
01P21 learning, memory, and nerve-cell study in normal micePubMed · FEBS Letters · Preclinical · 201002P021 tau study in aged ratsPubMed · Journal of Alzheimer’s Disease · Preclinical · 201503Early P021 study in an Alzheimer-like mouse modelPubMed · Alzheimer’s Research & Therapy · Preclinical · 201704P021 study in lab-grown human nerve cells and a mouse modelPubMed · Journal of Neurodevelopmental Disorders · Preclinical · 202405ClinicalTrials.gov intervention search for P021ClinicalTrials.gov · Trial registry · 2026
- Sources checked by
- Site editor · Editorial review